Skip to main content

ADVERTISEMENT

Verena Deserno, MS

Original Contribution
07/06/2010
   ABSTRACT: Background. Patients with metabolic syndrome (MetS) are at increased risk of cardiovascular events. The long-term effectiveness of sirolimus-eluting stents (SES) in patients with MetS and in diabetic patients is not well defined....
   ABSTRACT: Background. Patients with metabolic syndrome (MetS) are at increased risk of cardiovascular events. The long-term effectiveness of sirolimus-eluting stents (SES) in patients with MetS and in diabetic patients is not well defined....
   ABSTRACT: Background....
07/06/2010
Journal of Invasive Cardiology